← Back to Search

Dermal Filler

Allergan Vollure for Atrophic Scar (JVAS Trial)

N/A
Waitlist Available
Research Sponsored by Siperstein Dermatology
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 90 days after last injection
Awards & highlights

JVAS Trial Summary

This trial is testing Juvéderm Vollure, a new injectable filler, to see if it is safe and effective. Subjects will get Juvéderm Vollure on one side of their face and Saline on the other side. They will come back 30 days later and possibly get the Juvéderm Vollure again. They will fill out questionnaires and be assessed for short-term and long-term adverse events.

Eligible Conditions
  • Atrophic Scar

JVAS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 90 days after last injection
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 90 days after last injection for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Quantitiative Global Scaring Grading System (QGSGS) score
Secondary outcome measures
24 Month Global Aesthetic Improvement Scale (GAIS) Results
24 Month Quantitiative Global Scaring Grading System (QGSGS) Results
Adverse Events
+2 more

JVAS Trial Design

2Treatment groups
Experimental Treatment
Group I: Treatment With Juvederm Vollure RightExperimental Treatment1 Intervention
Injection of Juvederm Vollure on one half of the face, placebo on the other side
Group II: Treatment Juvederm Vollure LeftExperimental Treatment1 Intervention
Injection of Juvederm Vollure on one half of the face, placebo on the other side

Find a Location

Who is running the clinical trial?

Siperstein DermatologyLead Sponsor
3 Previous Clinical Trials
49 Total Patients Enrolled
AllerganIndustry Sponsor
781 Previous Clinical Trials
276,554 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment phase of this experiment open to participants?

"According to the clinicaltrials.gov database, this study is no longer enlisting patients for participation. This research was first launched on November 11th 2020 and its last update occured February 11th 2022. Nevertheless, there are still 185 other trials that have active recruitment drives in progress at present."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Vollure for the Correction of Atrophic Facial Scarring
2020. "Vollure for the Correction of Atrophic Facial Scarring". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04519515.
All > Scar
~3 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top